HSBC Holdings’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-47,000
| Closed | -$4.5M | – | 2927 |
|
|
2025
Q4 | $4.5M | Sell |
47,000
-21,400
| -31% | -$2.1M | ﹤0.01% | 1248 |
|
|
2025
Q3 | $6.68M | Hold |
68,400
| – | – | ﹤0.01% | 1079 |
|
|
2025
Q2 | $7.31M | Sell |
68,400
-38,700
| -36% | -$3.92M | ﹤0.01% | 1003 |
|
|
2025
Q1 | $10.7M | Sell |
107,100
-100,200
| -48% | -$10.1M | 0.01% | 875 |
|
|
2024
Q4 | $18.6M | Buy |
207,300
+121,600
| +142% | +$10.7M | 0.01% | 754 |
|
|
2024
Q3 | $7.12M | Sell |
85,700
-150,000
| -64% | -$11.8M | ﹤0.01% | 1001 |
|
|
2024
Q2 | $18.2M | Buy |
235,700
+150,000
| +175% | +$11M | 0.01% | 702 |
|
|
2024
Q1 | $5.87M | Buy |
85,700
+21,300
| +33% | +$1.37M | ﹤0.01% | 1043 |
|
|
2023
Q4 | $3.72M | Buy |
64,400
+7,000
| +12% | +$374K | ﹤0.01% | 1257 |
|
|
2023
Q3 | $3.04M | Buy |
57,400
+48,000
| +511% | +$2.52M | ﹤0.01% | 1282 |
|
|
2023
Q2 | $509K | Buy |
+9,400
| New | +$491K | ﹤0.01% | 1969 |
|
|
2023
Q1 | – | Sell |
-187,300
| Closed | -$8.62M | – | 2705 |
|
|
2022
Q4 | $8.62M | Buy |
187,300
+30,800
| +20% | +$1.33M | 0.01% | 1027 |
|
|
2022
Q3 | $6.15M | Buy |
156,500
+127,000
| +431% | +$5.09M | 0.01% | 1096 |
|
|
2022
Q2 | $1.11M | Buy |
+29,500
| New | +$1.2M | ﹤0.01% | 1872 |
|
|
2022
Q1 | – | Sell |
-6,200
| Closed | -$265K | – | 3274 |
|
|
2021
Q4 | $265K | Buy |
+6,200
| New | +$261K | ﹤0.01% | 2866 |
|
|
2021
Q3 | – | Sell |
-60,700
| Closed | -$2.58M | – | 2988 |
|
|
2021
Q2 | $2.58M | Buy |
+60,700
| New | +$2.55M | ﹤0.01% | 1339 |
|
|
2020
Q1 | – | Sell |
-178,700
| Closed | -$8.05M | – | 2717 |
|
|
2019
Q4 | $8.05M | Sell |
178,700
-46,000
| -20% | -$1.92M | 0.01% | 904 |
|
|
2019
Q3 | $9.14M | Buy |
224,700
+68,500
| +44% | +$2.9M | 0.02% | 893 |
|
|
2019
Q2 | $6.71M | Sell |
156,200
-2,700
| -2% | -$104K | 0.01% | 1022 |
|
|
2019
Q1 | $6.1M | Buy |
158,900
+89,900
| +130% | +$3.43M | 0.01% | 1031 |
|
|
2018
Q4 | $2.44M | Hold |
69,000
| – | – | ﹤0.01% | 1422 |
|
|
2018
Q3 | $2.66M | Hold |
69,000
| – | – | ﹤0.01% | 1365 |
|
|
2018
Q2 | $2.26M | Hold |
69,000
| – | – | ﹤0.01% | 1452 |
|
|
2018
Q1 | $1.89M | Buy |
+69,000
| New | +$1.88M | ﹤0.01% | 1439 |
|
|
2017
Q4 | – | Sell |
-68,700
| Closed | -$2M | – | 2073 |
|
|
2017
Q3 | $2M | Buy |
+68,700
| New | +$1.9M | ﹤0.01% | 1304 |
|
|
2017
Q2 | – | Sell |
-60,000
| Closed | -$1.49M | – | 2191 |
|
|
2017
Q1 | $1.49M | Buy |
60,000
+4,800
| +9% | +$117K | ﹤0.01% | 1306 |
|
|
2016
Q4 | $1.19M | Hold |
55,200
| – | – | ﹤0.01% | 1357 |
|
|
2016
Q3 | $1.31M | Buy |
55,200
+30,000
| +119% | +$716K | ﹤0.01% | 1285 |
|
|
2016
Q2 | $589K | Buy |
+25,200
| New | +$545K | ﹤0.01% | 1515 |
|
Other funds holding BSX
VCM
VPM
HSBC Holdings's BSX Position: Q1 2026 in Review
HSBC Holdings reduced its Boston Scientific (BSX) stake by 5.9% in Q1 2026, selling an estimated $17M and leaving 3,399,703 shares worth $213M. The position accounts for 0.11% of the portfolio, ranked #182.
HSBC Holdings first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $345M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- HSBC Holdings held 3,399,703 shares of Boston Scientific worth $213M as of Q1 2026.
- HSBC Holdings sold 212,549 Boston Scientific shares in Q1 2026, an estimated $17M.
- Boston Scientific made up 0.11% of HSBC Holdings's portfolio in Q1 2026, its #182 holding.
- HSBC Holdings first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Boston Scientific position peaked at $345M in Q4 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.